Spinal canal

Vertos Medical Promotes Two Senior Leaders to Newly Created C-Suite Roles

Retrieved on: 
Tuesday, August 15, 2023
LSS, Deloitte Technology Fast 500, Spinal canal, Vertos Medical, Quality of life, CCO, Research and development, Development, Patient, R, Lumbar spinal stenosis, Management, Pharmaceutical industry, Research

ALISO VIEJO, Calif., Aug. 15, 2023 /PRNewswire/ -- Vertos Medical Inc., a leader in the development of innovative, minimally invasive treatments for lumbar spinal stenosis (LSS), announced today that its Vice President of Sales, Stephen E. Paul, has been named chief commercial officer (CCO), and its Vice President of Research and Development, Mehrzad Khakpour, Ph.D., has been named chief technology officer (CTO) for the rapidly growing company. The promotions come on the heels of a recent Series C equity funding round of more than $26 million.

Key Points: 
  • The promotions come on the heels of a recent Series C equity funding round of more than $26 million.
  • Vertos Medical's proprietary technology, the mild® Procedure, has been shown in many studies to help restore mobility and decrease pain for LSS patients while greatly improving their quality of life.
  • Dr. Khakpour, previously Vertos' vice president of research and development, also boasts more than 20 years of experience in medical device research and innovation, with numerous notable past accomplishments.
  • In his newly created CTO position, he will oversee Vertos' upstream marketing, R&D, and clinical research teams to steer the company toward promising adjunctive innovations.

Curious Kids: how does your brain know how to move your body?

Retrieved on: 
Saturday, May 27, 2023
Extrapyramidal system, Heart, Spinal canal, Chocolate, Spinal cord, Head, Brain, Temperature, Movement, Stomach, Pain, Blood, Hearing, Joint, System, Headache, Tongue, Mouth, Saliva, Medical imaging, Mobile phone, Trapping

To answer it, we’ll need to look at some different parts of the brain and what they do.

Key Points: 
  • To answer it, we’ll need to look at some different parts of the brain and what they do.
  • First, the brain collects information
    The front part of the brain plans and makes decisions.
  • It does this after considering the different types of information it receives from “nerve cells”.
  • Read more: Curious Kids: how much does a brain weigh?

New Comparative Effectiveness Study Supports Surgical Treatment for Spinal Stenosis

Retrieved on: 
Wednesday, February 22, 2023
MBA, Cranial nerves, Journal, The Journal of Bone and Joint Surgery, New England Baptist Hospital, Laminectomy, Spondylolisthesis, Editorial, New England, Medicare, Patient, Face, Back pain, JBJS, Spinal stenosis, Spinal canal, Stenosis, Mortality, Master of Engineering, Wolters Kluwer, Big data, MD, Massachusetts General Hospital, Pharmaceutical industry, Nursing

BOSTON, Feb. 22, 2023 /PRNewswire/ -- In a large, national study, researchers reported unexpected findings that support the benefit of spine surgery for spinal stenosis over conventional medical treatment.

Key Points: 
  • BOSTON, Feb. 22, 2023 /PRNewswire/ -- In a large, national study, researchers reported unexpected findings that support the benefit of spine surgery for spinal stenosis over conventional medical treatment.
  • Using big data and predictive analytics, they compared clinically matched patients who received operative or nonoperative treatment of spinal stenosis and found that surgery was associated with lower mortality and cost over two years in some cases.
  • According to Wolters Kluwer Health, patients with spinal stenosis experience narrowing of the spinal canal and compression of spinal nerves, causing back pain, leg pain, and other symptoms.
  • In some patients, stenosis is related to degenerative spondylolisthesis, referring to "slipped" vertebrae often resulting from spinal degeneration.

Medcura Receives Breakthrough Device Designation for its LifeGel™ Absorbable Surgical Hemostat

Retrieved on: 
Thursday, January 12, 2023
Swelling, Spinal cord compression, Regulation of tobacco by the U.S. Food and Drug Administration, Bleeding, FDA, Partnership, Food, Paralysis, Thrombin, Breakthrough, Spinal canal, Birth control, Pharmaceutical industry

COLLEGE PARK, Md., Jan. 12, 2023 /PRNewswire/ -- Medcura, Inc., a medical device company dedicated to transformatively improving the management of surgical bleeding, announces that the U.S. Food and Drug Administration (FDA) has granted the coveted Breakthrough Device Designation for its LifeGel™ Absorbable Surgical Hemostat.

Key Points: 
  • COLLEGE PARK, Md., Jan. 12, 2023 /PRNewswire/ -- Medcura, Inc., a medical device company dedicated to transformatively improving the management of surgical bleeding, announces that the U.S. Food and Drug Administration (FDA) has granted the coveted Breakthrough Device Designation for its LifeGel™ Absorbable Surgical Hemostat.
  • Due to its no-swell properties, LifeGel can be used in surgical procedures where swelling cannot be tolerated.
  • Breakthrough designation provides several important benefits, including quicker and more collaborative review of future regulatory submissions with greater opportunity to interact with FDA experts throughout the review process.
  • "This designation provides for a more collaborative partnership with the FDA which should expedite patient access to LifeGel as a game-changing new solution to surgical bleeding management."

joimax® Experiences Major Growth, Launches TESSYS® TransSAP Endoscopic Surgical System

Retrieved on: 
Tuesday, October 18, 2022
General Health, Health, Surgery, Medical Devices, Method, Titanium, XT, Disease, Growth, Stenosis, Superior, Spinal canal, NASS, Multimedia, Technology, University, DWG, Spine, Neurology, Department, CEO, View, CNS, Animal testing at the University of Washington, Sacroiliac joint pain, Surgeon, Medical device, Aquaculture

Over the past 9 months, joimax has grown more than 25% globally and in the United States alone, more than 35%.

Key Points: 
  • Over the past 9 months, joimax has grown more than 25% globally and in the United States alone, more than 35%.
  • Among this major spurt, the market leader in technologies and training methods for full-endoscopic and minimally invasive spinal surgery is launching a new endoscopic surgical system, TESSYS TransSAP.
  • To keep momentum, joimax is releasing the TESSYS TransSAP the fourth addition to the TESSYS family encompassing the standard TESSYS Std, TESSYS XT featuring longer reach instruments, and TESSYS Thx, the optimized version for the thoracic spine.
  • All joimax implants can be safely inserted using the Over-the-Wire technique for precise implantation, making them ideal for endoscopically-assisted fusion procedures established and protected by joimax.

Research from the University of Birmingham, U.K., identifies new treatment target for CNS injury and neurological disease

Retrieved on: 
Thursday, September 15, 2022
Apoptosis, Institute, Enzyme, Multiple sclerosis, University of Birmingham, Movement, Spinal cord, Lists of diseases, Amyotrophic lateral sclerosis, Glaucoma, Neurodegeneration, Parkinson's disease, Spinal canal, Mentorship, Inflammation, Patient, Human Genome Sciences, Nerve injury, DDR, Cranial nerves, Neuroprotection, CHEK1, Alzheimer's disease, CNS, Research, DNA, Amyloid, Optic nerve, University, Patent, Sensation, Neuroregeneration, Disease, Medical device, Pharmaceutical industry, Trapping, Logging, Science Advances

The persistent activation of this system affects nervous system function and potentially triggers programmed cell death (apoptosis).

Key Points: 
  • The persistent activation of this system affects nervous system function and potentially triggers programmed cell death (apoptosis).
  • Professor Ahmed said: "Our research started out exploring DNA damage pathways activated following nerve injury.
  • Today's research paper follows two recently published studies in spinal cord injury from the same research group.
  • They then switched their attention to animal neurotrauma models of optic nerve damage and spinal cord injury.

Research from the University of Birmingham, U.K., identifies new treatment target for CNS injury and neurological disease

Retrieved on: 
Wednesday, September 14, 2022
Apoptosis, Institute, Enzyme, Multiple sclerosis, University of Birmingham, Movement, Spinal cord, Lists of diseases, Amyotrophic lateral sclerosis, Disease, Glaucoma, Neurodegeneration, Parkinson's disease, Spinal canal, Mentorship, Inflammation, Patient, Human Genome Sciences, Nerve injury, DDR, Cranial nerves, Neuroprotection, CHEK1, Alzheimer's disease, CNS, Research, DNA, Amyloid, Optic nerve, Multimedia, University, Patent, Sensation, Neuroregeneration, View, Medical device, Pharmaceutical industry, Trapping, Logging, Science Advances

The persistent activation of this system affects nervous system function and potentially triggers programmed cell death (apoptosis).

Key Points: 
  • The persistent activation of this system affects nervous system function and potentially triggers programmed cell death (apoptosis).
  • Professor Ahmed said: "Our research started out exploring DNA damage pathways activated following nerve injury.
  • Today's research paper follows two recently published studies in spinal cord injury from the same research group.
  • University of Birmingham Enterprise helps researchers turn their ideas into new services, products and enterprises that meet real-world needs.

joimax® Expands Distribution in China

Retrieved on: 
Friday, July 22, 2022
Health, Medical Devices, Technology, Surgery, Health Technology, Other Technology, Managed Care, Surgeon, Fortune, Spinal disc herniation, View, Education, Class, Partnership, Stenosis, Fortune Global 500, KOL, Technology, Patient, Adventist HealthCare White Oak Medical Center, Spinal canal, Shenzhen Kaifa Technology Co., Ltd., Sacroiliac joint pain, Medical device, Van Andel Institute

Under this new strategic partnership, Andeller will be the sole provider of joimax products to surgeons and medical practitioners throughout China.

Key Points: 
  • Under this new strategic partnership, Andeller will be the sole provider of joimax products to surgeons and medical practitioners throughout China.
  • Earlier this year, the distribution contract between joimax and Shanghai Maoyu Medical Equipment Co. Ltd. was terminated due to breach of contract and multiple violations by the Chinese company.
  • Moreover, the acclaimed joimax training and education programs will be rolled out to key opinion leaders (KOL), many of whom are longtime joimax users.
  • We are looking forward to working with Andeller, a strong and well-established partner in China, says joimax Founder and CEO Wolfgang Ries.

joimax® Announces Major Spike in Attendance at its ESPINEA® Workshops, Reports Record Revenues

Retrieved on: 
Wednesday, April 13, 2022
Surgery, Health, Other Health, Spinal canal, Faculty, Doctor of Science, Learning curve, Royal College of Surgeons of Edinburgh, MD, Stenosis, Learning, Patient, Sacroiliac joint pain, Growth, Surgeon, Literature, Spinal disc herniation, Publication, Advisory board, Curriculum, Multimedia, View, Royal college, Dentistry

German-based joimax, the market leader in technologies and training methods for full-endoscopic and minimally invasive spinal surgery, is excited to announce a major spike in attendance at its Endoscopic Spine Academy ( ESPINEA ) workshops, which contributes to sustainable growth, after another year of record revenues in 2021.

Key Points: 
  • German-based joimax, the market leader in technologies and training methods for full-endoscopic and minimally invasive spinal surgery, is excited to announce a major spike in attendance at its Endoscopic Spine Academy ( ESPINEA ) workshops, which contributes to sustainable growth, after another year of record revenues in 2021.
  • Moreover, the joimax-initiated workshop program, now under the umbrella of ESPINEA, offers optimal training for a variety of applications and procedures, making it attractive to a broader audience.
  • Together, with its growing team of faculty, joimax developed the complete six-step curriculum to bridge the learning curve for spine surgeons.
  • With the ESPINEA courses, surgeons can train on different procedures using the joimax TESSYS, iLESSYS, CESSYS, MultiZYTE, EndoLIF, Percusys based on the latest NAVENTO tower.

Worldwide Interspinous Spacers Industry to 2029 - Static Spacers for Lumbar Spinal Stenosis Treatment to Drive Growth - ResearchAndMarkets.com

Retrieved on: 
Tuesday, April 12, 2022
Medical Devices, Health, LSS, Ageing, Bleeding, Adoption, Spinal canal, Lumbar spinal stenosis, Population, Decompression, Research, Medtronic, Interspinous process decompression, Birth, Patient, Infection, Growth, Surgeon, NuVasive, Prevalence, Laminectomy, Risk, Pet, Antibiotics, Semiconductor

The global interspinous spacers market is segmented on the basis of product types, applications and geographical demarcation.

Key Points: 
  • The global interspinous spacers market is segmented on the basis of product types, applications and geographical demarcation.
  • Based on products, the static (compressible) spacers dominate the global market and shall retain its lead through the forecast period.
  • Evidence suggest that static interspinous spacers are the most cost-effective as against laminectomy in patients with lumbar spinal stenosis.
  • Among the applications, lumbar spinal stenosis (LSS) is the most prominent area experiencing the largest adoption of interspinous spacers.